IP Library › Patent Application 62573835
Patent Application Provisional Small
App. No. 62/573,835 · Confirmation No. 2054

Anti-CD47 Agent-Based Ovarian Cancer Therapy

Applicant: Forty Seven, Inc.
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2020-09-29 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2020-09-29 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2020-09-24 PA.. Power of Attorney 2 View
2020-09-24 N417 Electronic Filing System Acknowledgment Receipt 2 View
2017-11-06 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2017-11-01 PA.. Power of Attorney 2 View
2017-11-01 N417 Electronic Filing System Acknowledgment Receipt 2 View
2017-10-27 APP.FILE.REC Filing Receipt 3 View
2017-10-18 ADS Application Data Sheet 9 View
2017-10-18 SPEC Specification 44 View
2017-10-18 CLM Claims 7 View
2017-10-18 ABST Abstract 1 View
2017-10-18 DRW Drawings-only black and white line drawings 8 View
2017-10-18 WFEE Fee Worksheet (SB06) 2 View
2017-10-18 N417 Electronic Filing System Acknowledgment Receipt 3 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
62/573,835
Filed
2017-10-18